pdufa.bio
Home › Sources

Data sources & coverage

Updated ยทnext FDA decision on the calendar
What powers pdufa.bio, how often it updates, and what it does and doesn't cover. We publish our own metadata because a data source of record should.

Data source register

Every dataset behind this site, what it's licensed under, and whether we're allowed to redistribute it. We publish this because an accuracy brand that won't show its supply chain isn't one.

SourceWhat we use it forLicenceRedistribute?
FDA (openFDA, press, PDUFA reports)Decisions, approvals, CRLsPublic domainYes
SEC EDGAR8-Ks, PDUFA dates, cash runwayPublic domainYes
ClinicalTrials.govTrial design, NCT IDs, readout windowsPublic domainYes
Federal RegisterAdComm meeting noticesPublic domainYes
FINRAShort interest at catalystPublic domainYes
ChEMBLDrug modality & mechanismOpen (CC BY-SA)Yes, with attribution
Market data vendorsDaily prices, volumePaid licenceDerived statistics only: never raw
What we deliberately do not use. No competitor's calendar is republished here, not BioPharmaCatalyst, not any other. We use one privately as a QA yardstick to check our own coverage, and none of it ever reaches this site, the API, or the sitemap; that rule is enforced by a test that blocks deploys. We also removed a licensed DrugBank database from our repository rather than risk using it commercially.

Primary sources

FDA decision dates & outcomesFDA / company 8-K, 6-K, press releases; openFDA
Trial status & readout timingClinicalTrials.gov API v2
Cash runway & filingsSEC EDGAR (10-Q/10-K/8-K)

Update cadence

FDA decision dates, catalyst data and registry status are checked against primary FDA / SEC / ClinicalTrials.gov filings on an ongoing basis. Each catalyst carries a source type and a confidence level.

Coverage & honesty

We track upcoming U.S. FDA decisions (PDUFA) and a growing set of clinical readouts; the historic archive is being expanded and source-verified in batches: outcomes not yet verified are labeled price-only, not 'verified.' We are not affiliated with the FDA, we do not estimate per-drug approval probabilities, and every date can slip: verify against the primary filing. See our methodology.